The Department of Drug Administration has joined Nepal’s National Single Window System, operated by the Department of Customs, following a programme in Kathmandu on Thursday. Customs Director General Yam Lal Bhusal and Drug Administration Director General Bharat Bhattarai linked the department to the system, in a move expected to make procedures related to drug imports and regulation easier and more digital.
Two departments linked through the system
The connection brings the Department of Drug Administration into a system run by the Department of Customs. The link was established at a programme in Kathmandu, where the two departments’ director generals took part in connecting the drug administration department to the platform. The announcement marks an administrative step involving the agencies responsible for customs and drug administration.
The National Single Window System is the platform through which the Department of Customs is operating this arrangement. With the Department of Drug Administration now linked, procedures within the drug administration department’s area of responsibility are expected to be handled through a more digitised process. The stated focus of the move is on procedures connected with drug imports and regulation.
The participation of Bhusal and Bhattarai at the programme underscored the role of both departments in the linkage. Bhusal represented the department operating the system, while Bhattarai represented the agency being connected. The programme brought the two officials together in Kathmandu for the formal step described in the announcement.
Expected impact on drug-related procedures
The move is expected to ease procedures related to drug imports and regulation. Digitising those procedures is also an intended outcome of the connection. The announcement presents the system as a way to make relevant processes more straightforward, although it does not detail specific changes to individual applications, approvals or regulatory steps.
For people and organisations dealing with drug imports, the importance of the link will depend on how the digitised procedures are put into practice. The stated objective is to ease and digitise processes, rather than to announce a change to drug regulations themselves. The Department of Drug Administration’s role in drug regulation remains central to the subject of the new connection, while the National Single Window System provides the digital platform involved in the move.
The development therefore concerns the handling of procedures, not a reported change in the rules governing medicines or other drugs. No details in the announcement specify which particular services will be available through the system, how users will access them, or when individual procedures will shift to a digital format. The reported expectation is broader: that linking the department to the Customs-operated system will help ease and digitise work associated with imports and regulation.
Administrative step toward digitisation
The linkage adds the Department of Drug Administration to the National Single Window System and connects its work with a platform operated by the Department of Customs. The programme in Kathmandu formalised the connection through the involvement of the two departments’ director generals. Its stated purpose is to improve the handling of drug-related import and regulatory procedures through digitisation.
The move’s practical effect will be seen in how the relevant procedures are carried out after the department joins the system. For now, the announcement establishes the institutional connection and the expectation that processes will become easier and more digital. It does not describe a specific implementation schedule or list the services covered, so the details of how the change will affect individual procedures remain unspecified.
